Eastern Europe & Central Asia IP/ Trade developments & civil society Olena, All-Ukrainian Network of PLHIV Denis, ITPCru Raminta, EATG / OSF Civil Society.

Slides:

Advertisements

Similar presentations

External Trade 1 5th Global Congress Combating Counterfeiting and Piracy Global and Regional IPR Enforcement Initiatives Luc-Pierre Devigne Head of Intellectual.

Advertisements

The treatment of Government Procurement in international trade agreements: the EU experience Taipei, 11 June 2008 Christian Levon European Commission DG.

Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.

Differential pricing and access to medicines: issues and options Andrew Creese Essential Drugs and Medicines Policy Health Technology and Pharmaceuticals.

Ensuring generic competition for effective price reduction in Ukraine Olga Stefanyshyna Executive director CF «Patients of Ukraine» 24 th of July 2014.

Options for national or regional production or procurement Wilbert Bannenberg SARPAM.

Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.

The Emergence of Anti-Counterfeiting Legislation in East Africa: Implications for Generic Supply and Treatment Access Mandeep Dhaliwal Tenu Avafia With.

Recap of Day One Peter Chibatamoto. Opening Session Objectives of the workshop Opening remarks by NC – Cited a number of papers emphasizing the rationale.

“Using Competition Law to Promote Access to Health Technologies” Access to Innovation: Making Generic Versions of Newer ARVs Affordable 24 July 2014 Melbourne,

Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.

An Investment Compact for Black Sea Regional Co- operation By Dr. Rainer Geiger OECD, Co-Chair of SEE Investment Compact Conference on EU and Black Sea.

Regional Initiative on Agri-Food Trade and Regional Integration Europe and Central Asia Inclusive policy dialogue to make trade policies conducive to food.

Technical Cooperation to Improve Transparency and Accountability of Public Procurement in Transition Countries MICHEL NUSSBAUMER Head of Legal Transition.

ECUO's efforts in avoiding TRIPS + in Eastern Europe and Central Asia ECUO 23 July, 2014 Melbourne Australia Alexandra Volgina and Tetyana Pinska East.

Presentation to Civil Society meeting Lusaka 1 October 2013.

Assessing the impact of TRIPS-plus provisions on Public Healh: Lessons from Latin America David Vivas Eugui WTO Public Forum CSEND Roundtable.

1 ICC and AIPLA Paris, September 13, 2002 Felix Addor Chief Legal Officer and Deputy Director General Swiss Federal Institute of Intellectual Property.

Intellectual Property and Access to Affordable Medicines: TRIPS Plus

Community Advisory Board in Eastern Europe and Central Asia Advocacy. Mobilization. Education.

A very short introduction to patents & access to medicines.

TRIPS flexibilities and examples which resulted in reduced medicine prices: Model legislation and compulsory licensing in Brazil Juliana V. Borges Vallini.

Community Views on Intellectual Property as a Barrier to Access UNITAID Meeting – 4th OCT Sarah Zaidi, International Treatment Preparedness Coalition.

Summing up the results of the Regional Advocacy Campaign Access to HIV treatment, implemented by Eastern Europe and Central Asia Union of People Living.

Washington D.C., USA, July 2012www.aids2012.org Intellectual Property-related challenges: A Latin America Perspective GraciaVioleta Ross

The emergence of an Enforcement Agenda Intellectual Property Rights and Access to Essential Medicines: Challenges and Opportunities in Free Trade Agreement.

Common themes TRIPS flexibilities – Assertion and erosion of flexibilities – Legal and regulatory reform – Use of flexibilities: opposition has generated.

UK Policy considerations on increasing access to medicines for the poor in developing countries. DEPARTMENT FOR INTERNATIONAL DEVELOPMENT.

Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.

Wilbert Bannenberg SARPAM

Hu Yuanqiong China Access to Medicines Research Group OSF Seminar Bangkok; Access to Medicines and IPR Advocacy in China -- Review and initial.

Ideas in Development The Potential Impact of WTO Accession, FTAs and Partnership & Cooperation Agreements (PCAs) on Access to Medicines.

European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS

Getting the best treatment to the most people possible Enabling policies: threats & opportunities MSF Access Campaign.

World Trade Organization (WTO) accession and implications for public health Sanya Reid Smith Third World Network Kiev 22 September

Medicine Prices, Availability, Affordability and Price Components in Kazakhstan, Kyrgystan, Tajikistan & Uzbekistan Margaret Ewen Health Action International.

Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.

UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.

PASOS (Policy Association Soros for an Open Society) Meruert Makhmutova, member of former PASOS Acting Board Web: Warsaw, April.

Involvement of PLWHA in the Decision Making Process Anastasia Kamlyk UNDP Consultant/Coordinator of Tides Foundation Grant program for HIV/AIDS Treatment.

International Marketing: Chapter 10 Key Concepts u Multinational market regions u Criteria for successful economic unions u Types of multinational market.

8-1 Copyright © 2009 Pearson Education, Inc. publishing as Prentice Hall International Business Part Three Theories and Institutions: Trade and Investment.

The past, present and future of trade in dairy products: Insights into the impact of reduced protection and increased globalization on once-protected industries.

Unit 15 Why Nations Trade.. Section 1-4 Why Nations Trade In a recent year, about 8 percent of all the goods produced in the United States were exported,

1 SADC POOLED PROCUREMENT STRATEGY FOR ESSENTIAL MEDICINES & HEALTH COMMODITIES AARTI PATEL: TA SADC PBP BOTSWANA NATIONAL TRIPS & IP WORKSHOP.

The Eastern European Alliance for Reproductive Choice (EEARC) was established in June 2008 thanks to support of ICMA and representatives from 11 countries,

DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA RECAP ON PROCEEDINGS OF DAY 1 George Mpundu.

Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,

Trade & Access to Medicines in India Centre for Trade & Development

 Drug Pricing and the Impact on Treatment Access - International Wim Vandevelde - European AIDS Treatment Group (EATG) 2010 HIV Research Catalyst Forum.

Regional specific aspects WS 1 : Mediterranean & Middle East.

Governance in Central and Eastern Europe Cheryl W. Gray Europe and Central Asia Region World Bank.

Georg Roebling European Commission DG Trade, 14 June 2005 Government Procurement - a regional and international perspective.

TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.

Monitoring of Pharmaceutical Supply in Countries of Eastern Europe, Central Asia and Caucasus Anna Żakowicz European AIDS Treatment Group Presented at.

BIICL Antitrust Conference London 2 May European Commission, DG Competition Philip Lowe A changing competition policy: Thinking back and ahead Philip.

Competition and Intellectual Property Protection in the Pharmaceutical Sector Alexey Ivanov Director, HSE-Skolkovo Institute for Law and Development Director,

Access to medicines challenges in Europe: What is wrong and the way forward Presented by: Rohit Malpani Director of Policy & Analysis, Access Campaign.

 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.

Role of innovation in state of the art healthcare delivery in Russia 27 October 2015, USRBC Annual Meeting.

TRADE NEGOTIATION ON PHARMACETICALS PRESENTED BY CHOGO,MALESO (092SIS10).

European Union support to the Ukraine Bratislava, 3 June 2016 Livia Vasakova, EC Representation in Slovakia.

How Pricing Affects Availability

Intellectual Property Protection and Access to Medicines

Making medicines, diagnostics and other commodities more affordable

Zhang Naigen University Professor , Fudan University

EU instruments of funding and technical assistance

22nd International AIDS Conference Amsterdam, 24 July 2018

Treat the world: Working united across diseases for quality and affordable treatment for all – AIDS 2018 TRIPS Flexibilities 0.2 Across Diseases Ellen.

Presentation transcript:

Eastern Europe & Central Asia IP/ Trade developments & civil society Olena, All-Ukrainian Network of PLHIV Denis, ITPCru Raminta, EATG / OSF Civil Society Sstrategy Meeting on the Future of Access to Medicines, BKK, Dec 2011

12+3 countries of different sizes and shapes Middle income, few low income Proximity to the EU Influence of patternalistic Russia

Increasing IP & data exclusivity protection WTO/FTA/EU accession – (Russia, Kazakhstan, Ukraine,...) – But national legislation goes even for higher protection (recent Ukraine Law on Medicines: higher data exclusivity protections than required via its agreements with WTO and EU) Regional Eurasian Patent Organization: gateway to register regional patents Customs union – impact to be reviewed Some flexibilities remain (competition law, CL/Gvt use..) Little understanding of the issues – Community (exceptions: Kyrgyzstan, Ukraine, 2-3 regional people – key success of the last 3 years) – Govnts (some more knowledge through regional UNDP workshops) – UNDP national offices..

Major problems with A2M? Local pharmaceutical industry – strategic priority (Russia, Ukraine, Kazakhstan) National budgets for meds increase but access 40-60% Quality – Probably some real problems / low quality standards at regulatory level and corruption, particularly for domestic production – All patient communities: generics are not good (we want European standard) Corruption in tenders & registration: – Russia pays higher prices for hepC, some ARV meds than in the EU; only six generic ARV registered/3 purchased – Ukraine: major HIV network’s efforts to increase transparency of procurement Enforcing patents: more activity and interest from big pharma HIV: Merck,GSK, Abbott/Ukraine.. Key issue - transparency

Community advocacy in A2M in Hepatitis C Tx advocacy – National commitment – Community organizing IP – Kyrgyzstan: Patent Law review, community organizing, mobilizing UNDP support – First attempts to influence FTA/WTO negotiations: KZ, Ukr – Advocacy around data exclusivity in Ukraine HIV: Reactive advocacy re ART access – Interruptions, tender monitoring